Same Arthritis Drug, Different Results: Why Treatment Nonresponse Is Not Your Fault
If two patients take the exact same medication, why does one recover while the other sees little to no improvement.
Search results for "targeted therapy"
When Large Breasts Become a Burden: Actress Kang Ye-won Opens Up About the Physical and Emotional Toll
Actress Kang Ye-won has spoken candidly about her lifelong struggle with having an excessively large chest, revealing that her physical and emotional...
When Pain Keeps You from Walking, Start with the Cause
Editor’s note: In Japan’s orthopedic community, specialists use the term "locomotive syndrome" to describe a decline in...
AI Boosts Precision in Identifying Causal Genes for Inherited Retinal Diseases
Inherited retinal diseases present significant diagnostic challenges: while many manifest with similar clinical...
When Both Partners Face Cancer: How Shared Diets and Lifestyles Shape Risk
"My spouse and I became cancer patients almost at the same time. Our youngest child is still small, and my wife keeps...
Why Stage 3 Breast Cancer Doesn’t Always Mean Immediate Surgery
“Shouldn’t it be removed as soon as possible — even a day sooner?” This reaction is common among patients and their...
Flowers, Spring Breezes, and Restful Sleep: Medellin Recasts Itself as a Healing City
Rimbaud’s ‘Best Sleep,’ Discovered in an Andean Valley Arthur Rimbaud, a leading poet of French Symbolism, wrote in his...
CAR-T Without Extracting Patient Cells? J&J Makes $785 Million Bet on In Vivo Therapy
Johnson & Johnson (J&J) is investing more than $785 million (approximately 1.11 trillion won) in next-generation "in...
Scalp-Injected RNA Hair Loss Drug Completes Phase 1b Dosing in Australia
OliX announced on August 4 that it has completed patient dosing in the Australian Phase 1b clinical trial for OLX104C...
Timing of Immune Cell Entry Dictates Anti-Cancer Defense in Hard-to-Treat Brain Tumors
Some immune cells surrounding a tumor actively attack it, while others create conditions that help it survive.